Picture of ORYZON Genomics SA logo

ORY — ORYZON Genomics SA News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Oryzon Says Nice & Green Applies For Conversion Of Bonds For 480,000 Euros

June 26 (Reuters) - Oryzon Genomics SA  ORY.MC :
    * INFORMS ON CAPITAL INCREASE BY CONVERSION OF CONVERTIBLE
BONDS
    * NICE & GREEN APPLIES FOR CONVERSION OF BONDS FOR AGGREGATE
NOMINAL AMOUNT OF 480,000 EUROS
    * CONVERSION PRICE OF EUR 1.8794 PER SHARE
    * INCREASED ITS SHARE CAPITAL BY TOTAL NOMINAL AMOUNT OF
12,770
EUROS BY ISSUING AND PUTTING INTO CIRCULATION 255,400 NEW
ORDINARY SHARES WITH PAR VALUE OF 0.05 EUROS EACH
    * NEW SHARES IN CO WILL BE ISSUED AT ISSUE PRICE OF EUR
1.8794 PER
SHARE (EUR 0.05 PAR VALUE PLUS EUR 1.8294 SHARE PREMIUM)
    * TOTAL SHARE PREMIUM OF 467,228.76 EUR AND EFFECTIVE AMOUNT
OF
CAPITAL INCREASE OF 479,998.76 EUR
    * FOLLOWING CAPITAL INCREASE, SHARE CAPITAL OF COMPANY HAS
BEEN
SET AT 3.1 MILLION EUROS

Source text for Eikon:  ID:nCNM4FS5zb   ID:nFWN3IG01A 
Further company coverage:  ORY.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on ORYZON Genomics SA

See all news